MedPath

ABBVIE PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:1
Not Applicable:3

Drug Approvals

72

TGA:72

Drug Approvals

EPKINLY epcoritamab 48mg/0.8mL solution for injection vial (404977)

Product Name
EPKINLY epcoritamab 48mg/0.8mL solution for injection vial
Approval Date
Jan 6, 2025
TGA

EPKINLY epcoritamab 4mg/0.8mL concentrate solution for injection vial (404978)

Product Name
EPKINLY epcoritamab 4mg/0.8mL concentrate solution for injection vial
Approval Date
Jan 6, 2025
TGA

SKYRIZI risankizumab 180 mg/1.2 mL solution for injection pre-filled cartridge with on-body delivery system (427219)

Product Name
SKYRIZI risankizumab 180 mg/1.2 mL solution for injection pre-filled cartridge with on-body delivery system
Approval Date
Nov 15, 2024
TGA

ALPHAGAN P 1.0 brimonidine tartrate 1 mg/mL eye drop bottle (421114)

Product Name
ALPHAGAN P 1.0 brimonidine tartrate 1 mg/mL eye drop bottle
Approval Date
Oct 23, 2024
TGA

VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial (372902)

Product Name
VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial
Approval Date
Mar 27, 2024
TGA

AQUIPTA atogepant 60 mg tablet blister pack (391362)

Product Name
AQUIPTA atogepant 60 mg tablet blister pack
Approval Date
Dec 12, 2023
TGA

AQUIPTA atogepant 30 mg tablet blister pack (421965)

Product Name
AQUIPTA atogepant 30 mg tablet blister pack
Approval Date
Dec 12, 2023
TGA

AQUIPTA atogepant 10 mg tablet blister pack (391361)

Product Name
AQUIPTA atogepant 10 mg tablet blister pack
Approval Date
Dec 12, 2023
TGA

RESTASIS (407824)

Product Name
RESTASIS
Approval Date
Apr 18, 2023
TGA

SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial (375984)

Product Name
SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial
Approval Date
Oct 5, 2022
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (75.0%)
Phase 2
1 (25.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.